Chien Chung Chen
Financieel Directeur/CFO bij Vita Genomics, Inc.
Profiel
Chien Chung Chen is currently the Chief Financial Officer at Vita Genomics, Inc. Previously, he worked as an Independent Director at Kuangli Bio-Tech Holdings Co. Ltd.
Chen received his undergraduate degree from Soochow University.
Actieve functies van Chien Chung Chen
| Bedrijven | Functie | Begin |
|---|---|---|
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Financieel Directeur/CFO | - |
Eerdere bekende functies van Chien Chung Chen
| Bedrijven | Functie | Einde |
|---|---|---|
| KUANGLI BIO-TECH HOLDINGS CO., LTD. | Directeur/Bestuurslid | - |
Opleiding van Chien Chung Chen
| Soochow University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KUANGLI BIO-TECH HOLDINGS CO., LTD. | Electronic Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Vita Genomics, Inc.
Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
